Eli Lilly & Co. News, Eli Lilly & Co. Quote, LLY Quote

Eli Lilly & Co. (NY:LLY) Delayed: 1184.63 -0.15 (0.01%)

Prev. Close

$1184.78

Today 6M 1Y 5Y

Open

$1186.05

52 Wk High

$88.16

52 Wk Low

$67.88

Day High

$1192.94

Day Low

$1168.47

P/E

274.22

EPS

$4.32

Volume

1,659,231

Friends, Peers and Foes (?): NVO, PFE, ABBV, HIMS, MRK (more...)

ALERTS | RSS

Sep 29, 2026 06:00 PM Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
Sep 29, 2026 07:01 AM Lilly study links Zepbound to more weight loss than Wegovy HD
Sep 29, 2026 07:00 AM Lilly's Zepbound (tirzepatide 10 mg and 15 mg) was associated with more weight loss than Wegovy HD (semaglutide injection 7.2 mg) in a new indirect treatment comparison
Sep 29, 2026 06:03 AM Lilly's orforglipron shows edge over oral semaglutide 25 mg in analysis
Sep 29, 2026 03:00 AM Lilly's Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison
Sep 28, 2026 01:20 PM Eli Lilly & Co. (LLY) CEO sees company doing more deals in untapped areas
Sep 28, 2026 10:10 AM CMS pumps $51M into rural Texas to fight diabetes and obesity
Sep 28, 2026 08:38 AM Eli Lilly (LLY) PT Raised to $1,500 at JPMorgan as Guidance Raise Expected
Sep 28, 2026 06:45 AM Lilly launches access initiative for diabetes drugs in low-income countries
Sep 28, 2026 06:45 AM Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICs

Entities mentioned with LLY

View All Entities